[Financing of enzyme treatment in Gaucher disease].
Wisløff
Finn
F
D017281:Cost of Illness; D016527:Drug Costs; D005380:Financing, Government; D005776:Gaucher Disease / Q000188:drug therapy / Q000191:economics*; D005962:Glucosylceramidase / Q000008:administration & dosage / Q000191:economics*; D017048:Health Care Costs; D006801:Humans; D018156:Journalism, Medical; D009664:Norway
D005962:Glucosylceramidase